117 related articles for article (PubMed ID: 36477590)
21. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic Drug Interaction Between Amlodipine and Tadalafil: An Open-Label, Randomized, Multiple-Dose Crossover Study in Healthy Male Volunteers.
Kim H; Lee SH; Jung J; Hong S; Lim HS
Drug Des Devel Ther; 2022; 16():425-433. PubMed ID: 35221673
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic drug interaction study using fimasartan and rosuvastatin in healthy volunteers.
Kang WY; Kim EH; Seong SJ; Gwon MR; Yang DH; Kim HJ; Lim MS; Lee HW; Yoon YR
Int J Clin Pharmacol Ther; 2016 Dec; 54(12):992-1003. PubMed ID: 27668695
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects.
Keyvanjah K; DiPrimeo D; Li A; Obaidi M; Swearingen D; Wong A
Br J Clin Pharmacol; 2017 Mar; 83(3):554-561. PubMed ID: 27628584
[TBL] [Abstract][Full Text] [Related]
25. Effects of paroxetine, a CYP2D6 inhibitor, on the pharmacokinetic properties of hydrocodone after coadministration with a single-entity, once-daily, extended-release hydrocodone tablet.
Kapil RP; Friedman K; Cipriano A; Michels G; Shet M; Mondal SA; Harris SC
Clin Ther; 2015 Oct; 37(10):2286-96. PubMed ID: 26350273
[TBL] [Abstract][Full Text] [Related]
26. A Randomized Phase 1 Pharmacokinetic Study Comparing the Potential Biosimilar LRG201902 With Liraglutide (Victoza
Mai G; Fan L; Li M; Zhang P; Gan C; Huang Q; Shentu J
Front Pharmacol; 2020; 11():610880. PubMed ID: 33584289
[No Abstract] [Full Text] [Related]
27. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
29. Bioequivalence evaluation of 2 tablet formulations of entecavir in healthy chinese volunteers: a single-dose, randomized-sequence, open-label crossover study.
Jin J; Liu J; Chen J; Zhao L; Ma Z; Chen X; Huang M; Zhong G
Arzneimittelforschung; 2012 Mar; 62(3):113-6. PubMed ID: 22282264
[TBL] [Abstract][Full Text] [Related]
30. Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects.
Gardin A; Gray C; Neelakantham S; Huth F; Davidson AM; Dumitras S; Legangneux E; Shakeri-Nejad K
Eur J Clin Pharmacol; 2018 Dec; 74(12):1593-1604. PubMed ID: 30105453
[TBL] [Abstract][Full Text] [Related]
31. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
Macha S; Sennewald R; Rose P; Schoene K; Pinnetti S; Woerle HJ; Broedl UC
Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
[TBL] [Abstract][Full Text] [Related]
32. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers.
Kale P
Front Pharmacol; 2014; 5():98. PubMed ID: 24847268
[TBL] [Abstract][Full Text] [Related]
34. No Relevant Pharmacokinetic Drug-Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects.
Kim YK; Hwang JG; Park MK
Drug Des Devel Ther; 2021; 15():1725-1734. PubMed ID: 33953542
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and Bioequivalence of Cefprozil for Suspension and Granule Formulation in Healthy Chinese Volunteers: Two Single-Dose Crossover Studies.
Lin PP; Wang CJ; Liu YP; Li T; Gao XM; Ma YP; Shi P; Li X; Wang LX; Cao Y
Adv Ther; 2021 Feb; 38(2):1130-1142. PubMed ID: 33340343
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y
Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410
[TBL] [Abstract][Full Text] [Related]
37. Safety and pharmacokinetic interaction between fotagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin in healthy subjects.
Ding Y; Zhang H; Li C; Zheng W; Wang M; Li Y; Sun H; Wu M
Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):725-731. PubMed ID: 33899649
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects.
Winter H; Egizi E; Murray S; Erondu N; Ginsberg A; Rouse DJ; Severynse-Stevens D; Pauli E
Antimicrob Agents Chemother; 2015 Feb; 59(2):1219-24. PubMed ID: 25512422
[TBL] [Abstract][Full Text] [Related]
39. Drug-drug interaction of ciprofol injectable emulsion with mefenamic acid capsules in healthy subjects.
Yang D; Hu Y; Ruan Z; Jiang B; Wang H; Xu Y; Hu M; Yan M; Lou H
Br J Clin Pharmacol; 2023 Oct; 89(10):3165-3174. PubMed ID: 37309663
[TBL] [Abstract][Full Text] [Related]
40. Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Zhai Y; Wu L; Zheng Y; Wu M; Huang Y; Huang Q; Shentu J; Zhao Q; Liu J
Drug Des Devel Ther; 2020; 14():3131-3142. PubMed ID: 32801649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
